Neo-Adjuvant Treatment in Primary Resectable Pancreatic Cancer: A Systematic Review and PRISMA-Compliant Updated Metanalysis of Oncological Outcomes.

Raffaello Roesel,Letizia Deantonio,Lorenzo Bernardi,Maria Luisa Garo,Pietro Majno-Hurst, Alberto Vannelli,Marco Cefalì,Maria Celeste Palmarocchi,Maria Carla Valli, Guido Pesola,Alessandra Cristaudi,Sara De Dosso

Cancers（2023）

引用 0|浏览6

暂无评分

摘要

NAT is associated with improved survival for patients with resectable pancreatic adenocarcinoma; however, the optimal treatment strategy has yet to be defined, and further studies are required.

查看译文

关键词

resectable pancreatic cancer, pancreatic adenocarcinoma, neoadjuvant chemotherapy, neoadjuvant chemoradiotherapy, neo-adjuvant treatment

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要